Physician profile
Gregory R Brevetti
NPI 1619954435
$3,193.22
in general payments reported to CMS, 2019-2025
16 companies · $15.60 in 2025
The $15.60 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2021: $302 · 2022: $457 · 2023: $1,316 · 2024: $724 · 2025: $15.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,588 · Travel and Lodging: $467.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,588.33 |
| Travel and Lodging | $467.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon INC. | $978.54 | 2022-2023 | Monarch Platform |
| Astrazeneca Pharmaceuticals LP | $505.26 | 2019-2024 | Fasenra |
| Intuitive Surgical, INC. | $505.15 | 2019-2024 | |
| Glaxosmithkline, LLC. | $239.57 | 2023 | Arexvy |
| Genzyme Corporation | $121.19 | 2023 | |
| Medtronic, INC. | $119.54 | 2022 | |
| La Jolla Pharmaceutical Company | $118.05 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $117.41 | 2019 | |
| Novo Nordisk INC | $104.32 | 2022 | |
| Covidien LP | $98.75 | 2019 | |
| Boston Scientific Corporation | $79.24 | 2022 | |
| Merck Sharp & Dohme LLC | $76.42 | 2024-2025 | Keytruda, Bridion |
| Stryker Corporation | $58.65 | 2021 | |
| Pfizer INC. | $26.21 | 2024 | |
| Abbvie INC. | $23.81 | 2024 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $21.11 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Brevetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.